Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04677166 · ClinicalTrials.gov registry record · NA
Coupling Negative Pressure Wound Therapy With Instillation
A NA study, sponsored by Loma Linda University.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04677166: Clinical Trial NA study, sponsored by Loma Linda University.
NCT04677166 is a NA study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04677166, a NA study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The objective of this study is to compare standard negative pressure wound therapy with negative pressure wound therapy coupled with instillation for optimal skin graft take. Either the V.A.C ULTA NPWT or V.A.C. VeraFlo Therapy systems with normal saline will be applied intra-operatively to split-thickness skin grafts of upper and lower extremity wounds and kept in place for a duration of four days. Following completion of four days, the skin graft with be assessed for percentage of take/adherence and will be covered with simple gauze dressings as needed.
Primary Outcome
percentage of skin graft take at time of wound vac take down (4 days post-op)
Interventions
- DEVICE Negative pressure wound therapy coupled with instillation
- DEVICE Standard Negative Pressure Wound Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-01-19 |
| Est. Completion | 2024-10-21 |
| Phase | NA |
Why NCT04677166 stopped before completion
NCT04677166 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Negative pressure wound therapy coupled with instillation is the first listed.
NCT04677166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04677166 about?
NCT04677166 is a clinical study titled "Coupling Negative Pressure Wound Therapy With Instillation". The objective of this study is to compare standard negative pressure wound therapy with negative pressure wound therapy coupled with instillation for optimal skin graft take. Either the V.A.C ULTA NPWT or V.A.C. VeraFlo Therapy systems with normal saline will be applied intra-operatively to split-th...
What is the current status of trial NCT04677166?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-01-19. Estimated completion is 2024-10-21.
What interventions are being tested in trial NCT04677166?
The interventions under investigation include: Negative pressure wound therapy coupled with instillation (DEVICE), Standard Negative Pressure Wound Therapy (DEVICE).
Who is sponsoring clinical trial NCT04677166?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04677166's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI